Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Biolife Solutions Inc | 8,707,165 | 8,707,165 | 0 | $161.52M | $186.59M | 14.25% | +$25.08M |
| Revolution Medicines, Inc.(RVMD) | 5,617,599 | 4,406,875 | -1,210,724 | $181.06M | $171.03M | 13.06% | -$10.02M |
| Sarepta Therapeutics, Inc.(SRPT) | 1,069,000 | 1,073,500 | +4,500 | $138.39M | $169.61M | 12.95% | +$31.22M |
| Standard BioTools Inc.(LAB) | 61,907,605 | 63,959,677 | +2,052,072 | $167.77M | $113.21M | 8.64% | -$54.56M |
| GeneDx Holdings Corp.CL A(WGS) | 3,136,411 | 3,526,411 | +390,000 | $28.64M | $92.18M | 7.04% | +$63.54M |
| Avidity Biosciences Inc | 2,084,841 | 2,084,841 | 0 | $53.21M | $85.17M | 6.50% | +$31.96M |
| Relay Therapeutics, Inc.(RLAY) | 7,423,574 | 8,448,574 | +1,025,000 | $61.62M | $55.08M | 4.21% | -$6.53M |
| Illumina, Inc.(ILMN) | 248,000 | 480,000 | +232,000 | $34.06M | $50.10M | 3.83% | +$16.05M |
| Intellia Therapeutics, Inc.(NTLA) | 1,875,000 | 2,000,000 | +125,000 | $51.58M | $44.76M | 3.42% | -$6.82M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 358,000 | 170,000 | -188,000 | $53.50M | $41.31M | 3.15% | -$12.19M |
| Blueprint Medicines Corp | 326,378 | 326,378 | 0 | $30.96M | $35.18M | 2.69% | +$4.22M |
| Denali Therapeutics Inc.(DNLI) | 1,300,000 | 1,300,000 | 0 | $26.68M | $30.19M | 2.30% | +$3.51M |
| Structure Therapeutics IncADS | 1,116,867 | 700,000 | -416,867 | $47.87M | $27.49M | 2.10% | -$20.38M |
| Endeavour Silver Corp.(EXK) | 650,000 | 650,000 | 0 | $44.89M | $27.46M | 2.10% | -$17.43M |
| Tenaya Therapeutics, Inc.(TNYA) | 6,732,971 | 6,732,971 | 0 | $35.21M | $20.87M | 1.59% | -$14.34M |
| Neurogene Inc.(NGNE) | 524,616 | 524,616 | 0 | $26.70M | $19.09M | 1.46% | -$7.61M |
| Veracyte, Inc.(VCYT) | 857,904 | 857,904 | 0 | $19.01M | $18.59M | 1.42% | -$420.4K |
| 4d Molecular Therapeutics In | 800,000 | 800,000 | 0 | $25.49M | $16.79M | 1.28% | -$8.70M |
| Beam Therapeutics Inc.(BEAM) | 675,000 | 675,000 | 0 | $22.30M | $15.82M | 1.21% | -$6.49M |
| Verve Therapeutics Inc | 3,059,094 | 3,059,094 | 0 | $40.62M | $14.93M | 1.14% | -$25.70M |
| Century Therapeutics, Inc.(IPSC) | 3,206,380 | 5,190,506 | +1,984,126 | $13.40M | $13.24M | 1.01% | -$166.9K |
| Pliant Therapeutics, Inc.(PLRX) | 1,000,000 | 1,000,000 | 0 | $14.90M | $10.75M | 0.82% | -$4.15M |
| Tango Therapeutics, Inc.(TNGX) | 1,188,349 | 1,188,349 | 0 | $9.44M | $10.20M | 0.78% | +$760.5K |
| 2seventy Bio Inc | 2,000,000 | 2,000,000 | 0 | $10.70M | $7.70M | 0.59% | -$3.00M |
| Codexis, Inc.(CDXS) | 2,000,000 | 2,000,000 | 0 | $6.98M | $6.20M | 0.47% | -$780.0K |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 296,666 | +296,666 | $0 | $5.22M | 0.40% | +$5.22M |
| Kyverna Therapeutics, Inc.(KYTX) | 150,000 | 575,000 | +425,000 | $3.73M | $4.31M | 0.33% | +$586.5K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 150,000 | 150,000 | 0 | $3.57M | $3.08M | 0.24% | -$490.5K |
| Absci Corporation | 973,260 | 973,260 | 0 | $5.53M | $3.00M | 0.23% | -$2.53M |
| Guardant Health, Inc.(GH) | 0 | 100,000 | +100,000 | $0 | $2.89M | 0.22% | +$2.89M |
| Prime Medicine, Inc.(PRME) | 367,175 | 367,175 | 0 | $2.57M | $1.89M | 0.14% | -$682.9K |
| Pacific Biosciences of California, Inc.(PACB) | 1,035,859 | 1,035,859 | 0 | $3.88M | $1.42M | 0.11% | -$2.47M |
| GRAIL, Inc.(GRAL) | 0 | 79,999 | +79,999 | $0 | $1.23M | 0.09% | +$1.23M |
| Exscientia PlcADS | 213,900 | 213,900 | 0 | $1.22M | $1.09M | 0.08% | -$132.6K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 510,882 | 261,014 | -249,868 | $3.60M | $976.2K | 0.07% | -$2.63M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 1,459,747 | 1,459,747 | 0 | $1.69M | $488.0K | 0.04% | -$1.21M |
| Singular Genomics Systems In | 0 | 44,129 | +44,129 | $0 | $372.9K | 0.03% | +$372.9K |
| Kronos Bio Inc | 123,839 | 123,839 | 0 | $161.0K | $153.6K | 0.01% | -$7.4K |
| AbCellera Biologics Inc.(ABCL) | 2,360,129 | 0 | -2,360,129 | $10.69M | $0 | — | -$10.69M |
| Singular Genomics Systems In | 1,323,885 | 0 | -1,323,885 | $680.7K | $0 | — | -$680.7K |